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Available online 19 November 2016Inhalation exposure to low toxicity and biodurable particles has shown to induce polymorphonuclear neutrophilia
(PMN) in the lungs, which is a strong indicator for lung inﬂammation. Recently, Schmid and Stoeger (2016; http://
dx.doi.org/10.1016/j.jaerosci.2015.12.006) reviewedmice and rat intratracheal instillation studies and assessed the
relation between particles dry powder BET surface area dose and PMN inﬂux for granular biodurable particles
(GBPs) and transition metal oxides. In this study, we measured workers alveolar lung deposited surface area
(LDSA) concentrations (μm2 cm−3) during injection molding of polypropylene (PP) car bumpers and production
of tungsten-carbide-cobalt (WCCo)ﬁne grade powder using diffusion chargers. First order risk assessmentwas per-
formed by comparing the doses calculated from measured LDSA concentrations during an 8-h work day with the
NOEL1/100, the one hundredth of no observed effect level, assigned for GBPs (0.11 cm
2 g−1) and transition metal
oxide particles (9 × 10−3 cm2 g−1). During the injection molding of PP car bumpers, LDSA concentrations varied
from 23 to 39.8 μm2 cm−3. During 8-h exposure PP, particle doses were at a maximum of 1.4 × 10−3 cm2 g−1,
which was a factor 100 lower compared to the NOEL1/100 assigned for GBPs. In the WCCo ﬁne powder production
plant, the LDSA concentrations were below 18.7 μm2 cm−3, which corresponds to the 8-h dose of
2.7 × 10−3 cm2 g−1. This is 3 times lower than the NOEL1/100 assigned for transition metal oxide particles. The
LDSA concentrationswere generally low compared tourban background levels of 44.2 μm2 cm−3 in European cities.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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In an occupational environment, particle concentrations in air can be
highly elevated compared to the background due to high energy process-
es and use of chemicals that lead to particle formation (Hämeri et al.,
2009). Process generated particles and increasing use of engineered
nanomaterials (Vance et al., 2015) present new challenges to understand
exposure, hazard and risk management in occupational environments
(Hämeri et al., 2009; Pietroiusti and Magrini, 2014; Bekker et al., 2015).
Currently, only few occupational exposure limit values exist for par-
ticulate matter (PM) and are usually given in inhalable (PM10;
Dp ≤ 10 μm) or respirable (PM4.0; Dp ≤ 4.0 μm) mass concentration
(Cherrie et al., 2013; Kuempel et al., 2014). However, many studies
have shown that PM10 or PM4.0 mass concentration is only a rough. This is an open access article underindicator for a biologically effective dose of the complex mixture of air-
borne particles (Oberdörster, 2000;Maynard and Kuempel, 2005; Borm
et al., 2007; Wittmaack, 2007; Gebel, 2012; Simkó et al., 2014; Schmid
and Stoeger, 2016; Braakhuis et al., 2016). There is a need to develop
risk assessment techniques where PM exposure and dose assessment
is closely related to the biological response (Pietroiusti and Magrini,
2014).
For regulatory purposes and efﬁcient hazard assessment,
nanomaterials can be grouped according to their intrinsic physical prop-
erties and biological interactions (Arts et al., 2014, 2015, 2016;
Braakhuis et al., 2016; Dekkers et al., 2016; Godwin et al., 2015). Gran-
ular biodurable particles (GBPs) are the largestmaterial group consider-
ing their material production volumes and use (Piccinno et al., 2012).
GBPs are classiﬁed as low toxicity particles (Moreno-Horn and Gebel,
2014; Arts et al., 2016) although all GBPs may cause inﬂammation de-
pending on the deposited dose. Ongoing inﬂammatory processes may
cause secondary mutagenicity that may ﬁnally lead to lung cancerthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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ed in the lung (lung deposited surface area; LDSA) is recognized to be a
relevant dose metric to describe toxicological outcomes for a range of
different sizes of GBPs of the same chemical composition and morphol-
ogy after inhalation (Oberdörster et al., 2005; Stoeger et al., 2007, 2009;
Waters et al., 2009; Braakhuis et al., 2016; Schmid and Stoeger, 2016).
An inﬂux of polymorphonuclear neutrophils (PMNs) in the lungs is a
hallmark of the onset of inﬂammation after PM exposure (Grommes
and Soehnlein, 2011). Lung inﬂammation is expected to be associated
with the dose in the alveolar region of the respiratory tract (Nieboer
et al., 2005) which is why LDSA is expected to more accurately deﬁne
the dose-response relationship (Lison et al., 2014). For example, for
TiO2 particles of two different sizes with the instilled dose expressed
as mass, nano-sized particles induce a greater inﬂammatory response
in the lung than micron-sized particles. However, with the dose
expressed as particle surface area, the neutrophil responses ﬁtted the
same dose-response curve (Oberdörster et al., 2005).
In this study,wemeasuredworkers exposures in a factory producing
polypropylene (PP) car bumpers with injection molding and in a tung-
sten-carbide-cobalt (WCCo) ﬁne grade powder production plant. The
PP was colored using organic pigment nanoparticles and WCCo is clas-
siﬁed as nanomaterial. In both facilities the exposure to engineered
nanomaterials cannot be ruled out, therefore a Tier 2 exposure assess-
ment was performed (OECD, 2015). PM concentrations were measured
from near ﬁeld (NF) and far ﬁeld (FF) with two miniature diffusion size
classiﬁers and airborne particles were collected for Transmission Elec-
tronMicroscopy (TEM) analysis. A ﬁrst order risk assessment for inhala-
tion exposure based on pulmonary inﬂammation was performed by
assuming that the PMN surface area dose-responses assigned by
Schmid and Stoeger (2016) can be compared to the doses calculated
from measured LDSA concentrations during 8-h exposure.
2. Materials and methods
2.1. Injection molding
An injection molding machine (Engel, 2500 tons, Engel Austria
GmbH, A-4311 Schwertberg) was used to manufacture PP components
with a weight of 1.59 kg. Three different PP materials were molded:
• Natural color PP (PP0; KSR4525, Borealis AG, Vienna, Austria)
• PP containing 20 wt% mineral ﬁller (PPH; Hifax TRC 221P/2 G14008
OTOPHT, Mat no.: 19301A42, LyondellBasell, Ferrata, Italy)
• PP containing 0.2wt% organic pigment (PPOP; di-keto-pyrrolo-pyrrole
pigment, CAS-Nr. 84632-65-5, SUN FP-7 project provided by BASF
Schweiz AG, Switzerland; see also Sotiriou et al., 2016)Fig. 1. Layout of the process areas a) in the injection mInjectionmoldingwas performed in a naturally ventilated industrial
hall (area N 2500m2; T=N/A; RH=N/A; Fig. 1a). In addition to the in-
jection molding, an electric forklift was used occasionally. During the
second, day painting was performed in a paint booth approximately
30 m from the injection molding area. A blow torch was used occasion-
ally to smooth PP bumper holder parts which were cut off with a knife.
2.2. Sieving and milling
WCCo ﬁne powder was manufactured by fragmenting ca. 1 cm3
WCCo pieces with a high energy ball mill (technical information N/A).
The high energy ball mill was located in a ventilated cabin (air exchange
ratio N/A) where the replacement air was unﬁltered outdoor air from
the production hall (Fig. 1b). After milling, the WCCo powder was
sieved using a vibrating sieve with a 38 μm pore size. The material
was added to the sieve via an open feed funnel which had local exhaust
ventilation (volume ﬂow N/A). The sieve was switched off when the
bucket with sieved powder was replaced with an empty one. The
sieve was located in a partly closed room located in the production
hall (Fig. 1b). During the measurements, Iron-based, Nickel-based and
Titanium-based powders were milled and handled in other parts of
the facility. During thework tasks, workers wore ﬁltering facepiece res-
pirators (type FFP2, manufacturer N/A).
2.3. Measurement strategy
Particle concentrations were measured with two Miniature Diffu-
sion Size Classiﬁers with a 0.7 μm pre-separator (DiSCmini, Matter
Aerosol AG, Wohlen, Switzerland). During the injection molding, con-
centrations were measured simultaneously 1.5 m from the mold and
from aworkstation (Fig. 1a). In theWCCo ﬁne powder production, con-
centrations were measured simultaneously 0.5 m from the sieve and
from in the process hall or the high energy mill cabinet and the process
hall (Fig. 1b).
The DiSCmini instrument functions through unipolar charging of
particles and detection of their carried charge in two electrometer
stages. In the ﬁrst stage, the diffusion stage, where particles are detected
mainly due to their inherent Brownian motion. In the second stage, the
ﬁlter stage, the remainder of the particles is detected. Based on the ratio
of the two electrometer signals, an average particle size, Dp, can be cal-
culated as smaller particles undergo larger Brownian motion and will
thus be more likely to be detected in the ﬁrst stage (Fierz et al., 2011).
This average particle size can then be used to calculate a number con-
centration, assuming a Geometric Standard Deviation (GSD) of 1.7,
from the summed measured currents as the efﬁciency of the chargingolding and b) in the WCCo sieving and milling.
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measures particle number concentration within ±30% as compared to
results from Condensation Particle Counters (CPC) and ScanningMobil-
ity Particle Sizers (SMPS; Fierz et al., 2011, Asbach et al., 2012). Howev-
er, Bau et al. (2014) reported cases of poorer correlation, with ratios
ranging from−51% to +65% as compared to a CPC. They also reported
the Geometric Mean Diameter (GMD) to be within ±38% as compared
to a SMPS. Furthermore, Fierz et al. (2011) showed that the particle size
measured by the DiSCmini was underestimated for narrow size distri-
butions (GSD b 1.5) and overestimated for wide distributions
(GSD N 2.1).
For particles smaller than 300 nm there is a good correlation be-
tween the total current carried by the aerosol particles and the alve-
olar LDSA (Asbach et al., 2009). Fierz et al. (2011) reported a ± 20%
measurement ratio in the size range of 16 to 240 nm. Todea et al.
(2015) reported that alveolar LDSA measurements were within
±30% of theoretical values for particles between 20 and 400 nm. Fur-
thermore they reported that the DiSCmini underestimates the alveo-
lar LDSA for 20 nm particles and for large size particles (−62% for
685 nm particles).
2.4. Particle characterization
Airborne particles were collected on Cu TEM grids with formvar car-
bon foil (Plano, Wetzlar, Germany) using a mini particle sampler (Qs=
0.58 L min−1; Ecomeasure, Saclay, France; R'mili et al., 2013). Samples
were analyzed in a TEM Tecnai T20 G2 (FEI, Eindhoven, The Nether-
lands) operated at 200 kV. High-resolution (9.1625 pixel/nm) to over-
view (0.0045 pixel/nm) images were recorded with DigitalMicrograph
software (Gatan Inc., Pleasanton, VA, USA) using a bottom mounted
camera (Gatan US1000). For size analysis, overview images were post
processed with ImageJ 1.50i software (W. Rasband, National Institute
of Health, USA). The diameter discussed in connection with the micros-
copy images refers to equivalent area diameter of a circle of the pixel
size.
2.5. Estimation of the risk to develop pulmonary inﬂammation
Recently, Schmid and Stoeger (2016) studied the acute inﬂux of
PMNs into the lungs of rats and mice after single intratracheal instilla-
tion exposure to spherical particles, expressed as function of dose per
BET surface area normalized with lung weight. The studied materials
comprised polystyrene, two types of titanium dioxides, six types of car-
bonaceous materials, hydrothermally synthesized α-crystalline silica,
and Co-, Ni-, and Zn transitionmetal oxides. The relation of dry powder
BET surface area dose normalized with the lung weight DSA,BET (cm2
g−1) and PMNs (%) expressed as number of PMN cells normalized to
total number of cells was
PMN %ð Þ ¼ 11:0 ln DSA;BET
 
−26:7:
The maximum observed PMN level accounted for 60% of the total
number of cells; the geometric mean of half the maximal effective
dose for PMNs was 175 cm2 g−1 (GSD 2.2) for GBPs and 15 cm2 g−1
for transition metal oxide particles. The PMN no observed effect level
(NOEL; no inﬂammation) was between 0 and 5% corresponding to a
GBP dose between 11 and 18 cm2 g−1. The NOEL level was divided
with a default 100-fold factor (NOEL1/100) to take inter-species variation
between mice or rats and intra-species variation between humans into
account (ECHA, 2009). This corresponds to a NOEL1/100 of 0.11 cm2 g−1
for GBPs and 9 × 10−3 cm2 g−1 for transition metal oxides.
The surface area dose (cm2) was calculated bymultiplying the LDSA
concentration (μm2 cm−3), measured with a DiSCmini, by a certain vol-
ume of inhaled air (12 m3: the inhalation rate for a 70 kg male during
light exercise is 25 Lmin−1 (Freijer et al., 1997; ECHA, 2016)which cor-
responds to a total inhaled volume of 12 m3 during 8-h breathing). Thesurface area dose was normalized using the weight of the lungs from a
normal male of 840 g (Molina and DiMaio, 2012). The human
equivalent surface area dose (cm2 g−1) was compared with the NOEL
level to estimate a workers risk for acute lung inﬂammation by follow-
ing the conceptual approach presented by Oller and Oberdörster
(2010). The risk assessment is performed with the following critical
assumptions:
1) Particles emitted by the processes are spherical and comparable in in-
ﬂammatory responses to GBPs and transition metal oxide particles
used in Schmid and Stoeger (2016). The particles in the injection
molding were somewhat spherical (Fig. 5), and PP is a hydrophobic
and inert material that does not degrade in vivo (Maintz, 2015). In
the WCCo production plant, particles containing W, Ni, and Co
were aggregated or agglomerated and their aspect ratio increased
with increasing agglomerate/aggregate diameter (Fig. 6).
2) The human equivalent deposited surface area dose is equal to the LDSA
concentration × inhaled volume/lung weight. LDSA concentration can
be measured in an optimal case with an accuracy of ±30% for parti-
cle sizes between 20 and 400 nm (Todea et al., 2015). The volume of
inhaled air during 8-h may vary from ca. 5 m3 to 50 m3 if the work
load varies from resting (e.g. monitoring) to heavy exercise (e.g.
lifting; Freijer et al., 1997). The inﬂuence on the breathing volume
by the human total body weight is relatively small; a 90 kg male
would breathe 18% more air during 8-h than a 70 kg male (Freijer
et al., 1997). Particle deposition efﬁciency depends on the inhalation
rate (Hussain et al., 2011) and hygroscopic properties. Hydrophilic
particles N100 nm in diameter may grow up to 4 times larger in
95% relative humidity (Vu et al., 2015). Healthy men aged 18 to
35 years with a total body weight between 48.5 and 153 kg have a
mean weight of the right lung of 445 g (range from 185 to 967 g)
and the left lung of 395 g (range from 186 to 885 g) while lung
weights in women are ca. 25% smaller (Molina and DiMaio, 2012).
3) The dry powder BET surface area corresponds to the LDSA. Particle sur-
face area depends on themeasurement technique (Ku andMaynard,
2005; Ku and Kulkarni, 2012). LeBouf et al. (2011) showed that the
surface area measured with a diffusion charger differed from the ﬁl-
ter-based inert gas adsorption (BET method) measurement tech-
nique 1.27 to 5.77 times for ultraﬁne particles and 0.39 to 0.75
times for ﬁne particles for TiO2 particles at low and high concentra-
tion, respectively.
4) An equal instilled dose is equivalent to the inhaled alveolar dose calcu-
lated from LDSA concentrations. This is valid only if the particle depo-
sition distribution to the lungs and lung clearances are similar after
inhalation and instillation (Brown et al., 2005; Jarabek et al., 2005).
A high dose rate following intratracheal instillation may overwhelm
alveolar macrophages whichmay lead to dysfunction and reduction
of lung clearance and alter the toxicological response (Baisch et al.,
2014; Morimoto et al., 2016). To our knowledge, the fraction of ma-
terial reaching the alveoli after instillation has not yet been studied.
Therefore, we make the above assumption.
5) An equal PMN response is assumed to occur at an equivalent dose in
both rats and mice (based on intratracheal instillation studies) and
humans (based on inhalation exposure). Here, the dose was normal-
ized with the lung weight, even though alveolar surface area is
often considered as an appropriate dosemetric to correlatewith pul-
monary inﬂammation (Jarabek et al., 2005; Oller and Oberdörster,
2010). Intratracheal instillation studies have shown to cause equal
or greater inﬂammation compared to the inhalation of nanoparticles
(Baisch et al., 2014; Morimoto et al., 2016; Horie et al., 2016). A 10-
fold factor was assigned for inter-species variation and a 10-fold fac-
tor for differences between species (ECHA, 2009). Shape and slope of
the dose-response for transition metal oxide particles was assumed
to be the same as for GBPs. However, the potency is larger as a PMN
increase occurring at 12 times smaller concentrations compared to
GBPs (Schmid and Stoeger, 2016).
Table 1
Uncertainties and knowledge gaps in exposure-, dose-, and dose-response assessment.
Exposure assessment Dose assessment Dose-response assessment
Quantity or
assumption
Uncertainty Quantity or assumption Uncertainty Quantity or assumption Uncertainty
Exposure level ˃ ± 30% Inhaled volume during 8-h N/A; 10-fold if there
is no information
about work load
Dry powder BET surface
area ≡ LDSA
N10-fold
Morphology and
composition of
particle
concentrations
Qualitative
information
only
Human weight inﬂuence on
inhaled volume for 70 and
90 kg persons
ca. ±20% Instilled dose ≡ calculated
inhaled alveolar dose
Dose distribution N/A; biological half time
N/A but expected to be higher in instillation
than in inhalation exposure
Injection molding:
PP ≡ GBPs
N/A Change in particle deposition
efﬁciency due to breathing and
change in particle size
ca. ±20% Dose response in instilled
dose ≡ inhaled dose
N/A but higher dose response is expected in
instilled dose than inhaled dose
WCCo production
particles ≡
transition metal
oxides
N/A Weight of lungs Range from 371 to
1852 g in men (44 to
220%)
Lungs in women are
on average 25%
smaller than in men.
Inter-species variation factor 10-fold
intra-species variation factor 10-fold
95% limits for GBPs NOEL level of
11 cm2 g−1
2.3 to 53 cm2 g−1
Transition metal oxide particles
PNM response is 12 times
smaller than GBPs response.
N/A
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in range of an order of magnitude (Table 1).
3. Results
3.1. Injection molding
During injection molding of car bumpers, the particle number and
LDSA concentrations in the nearﬁeld (NNF and LDSANF) remained at sim-
ilar levels as FF concentrations (Table 2, Figs. 2 and 3). Opening of the
mold and removal of the bumper did not elevate the concentrations no-
tably (Figs. 2 and 3). The PPﬁller did not effect on the emissions notably.
The geometric mean LDSANF levels were at their maximum 10% higher
than respective LDSAFF concentrations, which was mainly caused by re-
sidual particles from the polishing process at day 2 (ending at ca. 00:50,
see Fig. 3b). Thus, the particle concentrations from injection molding of
car bumpers were too low to detect with the DiSCmini's.
The PP material change showed increased ≤10% NNF and ≤33%
LDSANF geometric mean concentrations compared to the respective FF
concentrations. This was mainly caused by an increase in NF particle
sizes that were 6 to 23% larger in diameter, compared to the FF particles
(Table 2). Particle size increase was signiﬁcant especially during day 1
between 03:25 and 04:15 (Fig. 2c). This indicates that particles released
from injection mold polishing process are larger than particles released
during the injection molding process. This explains why the particle
number concentration, which is proportional to Dp0, remained at similar
level, but the LDSA concentration, which is proportional to ca. Dp1, were
increased. The particle emissions during change of one PP material to
another increased both the NF and FF concentrations (Figs. 2 and 3).
The particles analyzed on the TEM grids show patterns that suggest
that large droplets were collected and material recrystallized on theTable 2
Geometric mean and standard deviation in brackets of particle number concentration, lung d
percentages.
Process Near Field (NF) Far Field (FF)
NNF × 103
[cm−3]
LDSANF
[μm2 cm−3]
Dp,NF
[nm]
NFF × 103
[cm−3]
PPH 9.8 (1.34) 25.2 (1.13) 46.9 (1.2) 9.6 (1.2)
Polishing PPO 12.6 (1.35) 40.4 (1.62) 57.6 (1.36) 11.5 (1.13)
PP0 7.2 (1.08) 28.6 (1.06) 70.6 (1.03) 8.9 (1.11)
PPOP 14.8 (1.28) 45.5 (1.24) 55.5 (1.04) 15.5 (1.14)
Polishing PPOP 14.6 (1.46) 49.6 (1.42) 60.9 (1.06) 13.5 (1.22)
Sieving 3.5 (1.16) 10.0 (1.07) 51.2 (1.1) 4.4 (1.2)
Milling 3.9 (1.23) 13.2 (1.27) 60.5 (1.17) 4.7 (1.26)substrate (Fig. 5a and b). The average diameter of these (presumably re-
crystallized) particles is 56.8 nm (standard deviation 34.9; min 10.1;
max 126.6 nm) and their aspect ratio is 1.44 (standard deviation
0.29). In the size range below 50 nm, particles are mainly composed of
C, whereas in larger particles, S, Na and K are found (Fig. 5).
3.2. WCCo sieving and milling
Both in sieving and milling, the NNF and LDSANF concentrations were
16 to 29% lower as in the FF (Table 2, Fig. 4) during the same processes.
The NF particle sizes were similar in the sieving process, but 16% lower
in the milling process as in the FF (Table 2). This suggests that the con-
centrations were similar in the production hall as at the process sites
where the LDSA concentrations varied from 10 to 18.7 μm2 cm3.
Particle analysis on the TEMgrids showed that themajority ofWCCo
particles were agglomerated, occurring in the size range of 274 nm to
10.6 μm as pure particles (Fig. 6). Some were observed as internally
mixed in large, micrometer-sized aggregates with Ni-based particles
(Fig. 6a). Large aggregates of Ni-based particles coated with C were ob-
served in low number. The average aspect ratio of all analyzed particles
is 1.48 (standard deviation 0.4).
3.3. Estimation of the workers risk for acute pulmonary inﬂammation
During the injection molding, the geometric mean LDSANF concentra-
tions were elevated and ranging 0.5 to 5.7 μm2 cm−3; during PP material
change the LDSAFF concentration reached 10.0 μm2 cm3. This corresponds
to 8-h doses of 0.07 × 10−3 to 0.8 × 10−3 cm2 g−1 during the injection
molding and 1.4 × 10−3 cm2 g−1 during PP material change. Assuming
that PP particles have similar properties than GBPs (Fig. 5), the doses
are N80 times below the respective NOEL1/100 level of 0.11 cm2 g−1.eposited surface area, and particle size in the near ﬁeld and far ﬁeld and their ratios as
NF/FF–ratios × 100
LDSAFF
[μm2 cm−3]
Dp,FF
[nm]
NNF/NFF
[%]
LDSANF/LDSAFF
[%]
Dp,NF/Dp,FF
[%]
23.0 (1.08) 44.3 (1.13) 101 110 106
30.4 (1.31) 48.7 (1.21) 110 133 118
28.1 (1.1) 57.6 (1.03) 81 102 123
39.8 (1.11) 47.6 (1.04) 96 114 117
39.6 (1.19) 53.8 (1.05) 108 125 113
12.1 (1.09) 51.0 (1.17) 81 83 100
18.7 (1.32) 71.6 (1.15) 84 71 84
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2.7 × 10−3 cm2 g−1 and the particles contained e.g. Ni, W, and Co tran-
sition metals (Fig. 6). Assuming that the dose consists of only transition
metal oxides, the dose is ca. 3 times lower than the NOEL1/100 level of
9 × 10−3 cm2 g−1 for transition metal oxides.
4. Discussion
In the present study we used the LDSA exposure measurements from
twowork places to assess the risk forworkers, to develop a pulmonary in-
ﬂammation during 8-h exposures. The risk was estimated by comparing
the dose levels calculated from LDSA exposure levels with the NOEL1/100
levels derived from Schmid and Stoeger (2016). In injection molding at
the worst case exposure scenario the dose was 80 times below the
NOEL1/100 level for GBPs and in the WCCo ﬁne powder production plant
3 times below the NOEL1/100 level for transition metal oxide particles.
It is expected that the injection molding process is safe to perform
considering workers risk to suffer pulmonary inﬂammation for a single
exposure day. In theWCCo ﬁne powder production plant, it is suggested
to perform more detailed exposure analysis to verify the actual dose
level of transition metal oxide particles (e.g. assess fraction of transition
metal oxides in the airborne PM or collect powder samples to assess103
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sessment, the use of personal protective equipment was not taken into
account. According to Janssen et al. (2007) the protection factor of a
properly used facepiece respirator is 119 (GSD 3.0). This should be
enough to reduce the exposure at the levelwhere pulmonary inﬂamma-
tion is not expected to occur.
Systematic measurements of the alveolar LDSA concentrations are
still scarce but some ﬁrst studies provide an overview of the exposure
levels at urban environments, speciﬁc indoor environments, and occu-
pational settings. The average urban alveolar LDSA concentrations
vary in different cities from a geometric mean of 44.2 μm2 cm−3 (GSD
2.2) in background measurement sites to geometric mean of
64.5 μm2 cm−3 (GSD 1.9) in trafﬁc areas (Ntziachristos et al., 2007;
Buonanno et al., 2012; Gomes et al., 2012; Reche et al., 2011). Similar al-
veolar LDSA concentrations, ranging from ca. 20 to 60 μm2 cm−3, were
measured in urban areas in Switzerland (Eeftens et al., 2015). The per-
sonal LDSA exposures in different urban microenvironments in Como,
Italy, varied from ca. 10 to 90 μm2 cm−3 (Spinazzè et al., 2015).
Occupational alveolar LDSA concentrations has been shown to be
360 μm2 cm−3 in wood-ﬁred ovens pizzerias in Italy (Buonanno et al.,
2010) and in automotive plants 700 μm2 cm−3 (arithmetic standardPolishing PPOP Molding PPH
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35A.J. Koivisto et al. / NanoImpact 6 (2017) 30–38deviation 340 μm2 cm−3; Buonanno et al., 2011). Geiss et al. (2016)
measured average alveolar LDSA concentrations of 415 μm2 cm−3 in a
canteen kitchen, 77.2 μm2 cm−3 in a car, and 137 μm2 cm−3 during
welding. In a private house with wood burning stove and gas cooking
the average alveolar LDSA concentration was 54 μm2 cm−3 (Geiss et
al., 2016).
During the injectionmolding process, theNF and FF LDSA concentra-
tions varied from 23.0 to 45.5 μm2 cm−3 and the concentrations in theFig. 5. TEMbrightﬁeld images of particles on PPOP injectionmolding sample taken during day 2
composition (spectrum 1); b) carbon based (spectrum 2) and other, S-containing particles (spNFwere not elevated notably from the FF concentrations (Table 2). Sim-
ilar results were measured by Boonruksa et al. (2016) during injection
molding performed in an industrial laboratory. During the PP material
change, the NF and FF LDSA concentrations in this study varied from
30.4 to 49.6 μm2 cm−3 (Table 2). These concentrations are similar to
urban background concentrations (Reche et al., 2011).
In theWCCo production plant, the DiSCmini signalwas noisier in the
WCCo sieving and milling than in the injection molding. This points toat 1:36 a)mixedparticle and accordinglymarked energy-dispersive spectroscopy chemical
ectrum assimilates 1); c) overview image of carbon based and S-containing particles.
36 A.J. Koivisto et al. / NanoImpact 6 (2017) 30–38the presence of micron-sized particles, which can impact on the diffu-
sion stage. Even though the DiSCmini has a pre-seperator with a
0.7 μm D50 value, some larger particles can still penetrate it, which
may cause measurement problems. For example, a spherical 3 μm par-
ticle will have the same diffusion stage penetration as a 40 nm particle,
but due to the Dp1.1 dependency, it will carry a roughly 100 times higher
charge. Itwill therefore be interpreted as 100 small sized particles (Fierz
et al., 2011). Furthermore, as the D50 value of the pre-separator con-
cerns aerodynamic diameters, larger mobility size agglomerates with
particle density b 1 g cm−3 may still penetrate to the instrument at
high probability. The TEM images form samples taken in theWCCo pro-
duction plant showed irregular shaped agglomerated particles of differ-
ent sizes, which likely have a lower density than their compact material
equivalent. The samples from the injection molding showed indication
for large, droplet like particles. The collected particle might have been
more homogenous and compact than the agglomerated particles col-
lected during sieving and milling. The LDSA concentrations varied
from 10.0 to 18.7 μm2 cm−3. The concentrations were below one GSD
from urban background geometric mean concentrations of
20 μm2 cm−3.
4.1. Knowledge gaps in ﬁrst order risk assessment for inhalation exposure
based upon pulmonary inﬂammation
Table 1 show that there are major knowledge gaps in all steps of the
risk assessment: the exposure, dose, anddose-response assessment. Re-
garding exposure,workplace air PM characterization and conceptual in-
formation including working practices and work load are critical when
estimating exposure and dose of process particles. With respect to haz-
ard assessment, toxicological comparability of particles found at theFig. 6. TEM bright ﬁeld images of particles on sieving andmilling sample taken at 1:18 a) NiP ag
cobalt (WCCo) particle, and their accordingly marked energy-dispersive spectroscopy chemicawork place and the GBPs and transition metal oxide particles used in
previous dose-response assessment should be veriﬁed preferably with
dose-response studies using the particles collected from the workplace
air. Biodurability of particles at the workplaces should be veriﬁed.
Kühnel et al. (2012) showed that dissolution of tungsten and cobalt
from WCCo particles in Roswell Park Memorial Institute Medium with
and without 5% fetal bovine serum was 15% W and 76% Co after one
week.
The majority of the uncertainties are related to extrapolation from
dose-response data based on dry powder BET measurements of parti-
cles following intratracheal instillations to the human equivalent LDSA
dose-response (Table 1). The relation between dry powder BET surface
area and LDSA should be studied for differentmaterials for dose conver-
sion. This requires well-controlled inhalation studies where the air-
borne particles BET surface area concentrations, LDSA concentrations,
and size resolved particle concentrations are measured. After inhalation
of high particle concentrations the deposited particles may agglomerate
in the lung which effect on the BET surface area (Mercer et al., 2013).
The calculated deposited doses from measured concentrations should
be compared with actual deposited dose measured from lung tissue to
understand range of the uncertainty. The dose-responses following in-
halation exposures should be comparedwith the dose-responses deter-
mined in instillation studies to understand correlation between
inhalation uptake and instilled dose.
5. Conclusions
In this study, a workers risk to suffer acute pulmonary inﬂammation
was estimated by measuring alveolar lung deposited surface area
(LDSA) concentrations which were used to calculate process speciﬁcgregate; b) Tungsten-carbide-cobalt (WCCo) internally mixed FeCu; c) Tungsten-carbide-
l composition.
37A.J. Koivisto et al. / NanoImpact 6 (2017) 30–388-h doses. The acute pulmonary inﬂammation risk was estimated by
comparing 8-h doses with the no observed effect level divided with a
100 factor (NOEL1/100). The injection molding of polypropylene (PP)
car bumpers did not notably increase process site concentrations from
the far ﬁeld levels which ranged from 23 to 39.8 μm2 cm−3 but during
PP material change was measured an increase of on average
10 μm2 cm−3. The 8-h PP particle doses were at maximum
1.4 × 10−3 cm2 g−1 which was lower by a factor 100 compared to the
NOEL1/100 of 0.11 cm2 g−1 assigned for granular biodurable particles.
In the WCCo ﬁne powder production plant, the LDSA concentrations
were below 18.7 μm2 cm−3 which corresponds to the 8-h dose of
2.7 × 10−3 cm2 g−1 being 3 times below the NOEL1/100 of
9 × 10−3 cm2 g−1 for transition metal oxide particles. In general, the
LDSA concentrations were low compared to average geometric mean
urban background levels of 44.2 μm2 cm−3 in European cities.Acknowledgement
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